Pharmaceutical device development

Injection Pen OEM/ODM Manufacturing Services

Plan OEM/ODM injection pen projects for GLP-1, insulin, HGH and peptide applications with ISO 13485-certified manufacturing support.

Direct answer

What buyers need to know

Penacta coordinates injection pen OEM/ODM projects for GLP-1, semaglutide, tirzepatide, insulin, HGH/somatropin and peptide application contexts through an ISO 13485-certified manufacturing partner. Each project begins with the formulation, primary container, dose profile, users and target market—not color or logo alone.

Primary buyer task

Commercial and technical project scoping. Start with requirements that affect device function, then separate documented platform facts from items that still require project testing.

Selection and evidence checklist

Decision areaWhat to confirm
InputsFormulation category, container, dose profile and market
Platform fitExisting architecture versus functional modification
CustomizationColor, artwork, scale, packaging and instructions
VerificationRisk-based testing for every affected function
TransferApproved specification, samples and change control

A practical evaluation sequence

  1. Define the use case. Record the drug presentation, user, use environment and intended market.
  2. Lock the primary container. Confirm geometry, materials, closure and available drawings before assuming fit.
  3. Map the dose system. Keep concentration, volume, units, increment and range tied to one configuration.
  4. Review user interaction. Identify preparation, setting, actuation, feedback, disposal and foreseeable misuse.
  5. Plan evidence. Agree which claims require drawings, samples, verification, stability inputs or human-factors work.

Reference platforms

Start the OEM brief from a real product platform

Choose the closest reference architecture first. Customization discussions can then focus on the dose system, container, materials, appearance and packaging.

Application names describe procurement and development contexts, not confirmed drug-device compatibility. Final container, dose system, performance, regulatory pathway and production configuration require project-specific technical review.